Compass Financial Advisors’s Pfizer PFE Stock Holding History

Compass Financial Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,845	Closed	-$524K	–	68
2023 Q1	$524K	Sell	12,845 -62	-0.5%	-$2.68K	0.66%	52
2022 Q4	$661K	Sell	12,907 -69	-0.5%	-$3.31K	0.89%	37
2022 Q3	$568K	Buy	12,976 +16	+0.1%	+$777	0.84%	40
2022 Q2	$680K	Buy	12,960 +67	+0.5%	+$3.41K	0.93%	37
2022 Q1	$667K	Buy	12,893 +1,701	+15%	+$88.3K	0.74%	46
2021 Q4	$661K	Buy	+11,192	New	+$555K	0.73%	49

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Compass Financial Advisors's PFE Position: Q2 2023 in Review

Compass Financial Advisors sold out of Pfizer (PFE) in Q2 2023, closing a stake of 12,845 shares — an estimated $524K sold.

Compass Financial Advisors first reported a position in PFE in Q4 2021 and held it in 6 quarters. The position peaked at $680K in Q2 2022. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

Compass Financial Advisors reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
Compass Financial Advisors sold 12,845 Pfizer shares in Q2 2023, an estimated $524K.
Compass Financial Advisors first reported a position in Pfizer in Q4 2021 and held it in 6 quarters.
Compass Financial Advisors's Pfizer position peaked at $680K in Q2 2022.
3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Compass Financial Advisors's 13F filing for Q2 2023.